KETA.CN TripSitter Clinic Ltd. (CNQ) +226.67% 04 Feb 2026: high-volume trade insight

KETA.CN stock surged 226.67% to C$0.49 in market hours on 04 Feb 2026. The move shows a large price gap from yesterday’s close of C$0.15. Reported intraday volume is anomalous, so traders must watch liquidity and trade prints closely. TripSitter Clinic Ltd. (CNQ) operates a U.S. tele-health ketamine platform and remains small, with market cap C$3,262,505.00 and 6,658,174.00 shares outstanding. We review drivers, valuation, technicals, the Meyka grade, and scenario price targets for active traders and volume-sensitive investors.

Why KETA.CN stock moved today

The main fact: price jumped 226.67% from C$0.15 to C$0.49 on 04 Feb 2026. Reported day high and low are both C$0.49, and open matched the high. Market feeds show volume 0.00 for the session, while average volume is 1,134.00, so data lags or special trades may explain the print. There is no company press release in the feed. Traders should treat the move as a high-volatility event and verify trade prints and tape activity via their broker or market data vendor. For SEC/market filings context check source.

KETA.CN stock fundamentals and valuation

TripSitter Clinic Ltd. reports EPS -0.04 and a negative PE metric. Trailing PE shown is -12.25, reflecting losses. Price averages are low: 50-day average C$0.06 and 200-day average C$0.07. The company’s book value per share is negative at -0.12. Compared with the Canadian healthcare sector, KETA.CN is effectively a micro-cap, subscale operator with weak liquidity and limited revenue per share. These fundamentals make valuation sensitive to single trades or short-term investor flows.

Technical picture and liquidity for KETA.CN stock

Technical indicators show an irregular profile. RSI reads 0.00 and MACD is near -0.01, reflecting sparse data and very low trading history. ADX at 100.00 flags a strong trend in the feed, but that likely mirrors a single large print. On-chain volume metrics are unreliable here. Average volume 1,134.00 shares means wide spreads and execution risk. Active traders should use limit orders and expect price gaps. Observe order book depth before sizing positions.

Meyka AI rates KETA.CN with a score out of 100 and forecast

Meyka AI rates KETA.CN with a score out of 100: 59.35 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of C$0.08 and a quarterly price of C$0.06. Versus the current C$0.49, the monthly forecast implies -83.67% and the quarterly forecast implies -87.76%. Forecasts are model-based projections and not guarantees.

Risks and opportunities for KETA.CN stock

Key risk: extreme liquidity and negative book value increase execution and bankruptcy risk. Regulatory risk exists for prescription ketamine tele-health models. Financial risk is material given negative operating cash flow per share and tight cash per share. Opportunity: rising interest in psychedelic-assisted therapy could boost demand if TripSitter scales operations in U.S. states it serves. Any credible corporate update, capital injection, or strategic partner could change the outlook quickly.

Trading strategy and price targets for KETA.CN stock

For short-term traders, manage size and use strict stop limits due to low liquidity. Scenario price targets for active traders: Bull target C$0.80 (event-driven re-rating), Base case C$0.10 (mean-reversion to 50-day average), Bear target C$0.02 (capital erosion scenario). Targets reflect trade-based scenarios, not firm valuations. Confirm any move with volume above the 1,134.00 average and with order book depth. See the Meyka stock page for real-time charts Meyka stock page.

Final Thoughts

KETA.CN stock moved sharply in market hours on 04 Feb 2026, printing C$0.49 and a 226.67% change versus yesterday’s close. The print appears driven by an isolated trade or delayed data feed given reported volume 0.00 against an average of 1,134.00 shares. Fundamentals remain weak: negative EPS and negative book value increase downside risk. Meyka AI’s forecast model projects C$0.08 monthly and C$0.06 quarterly, implying downside of -83.67% and -87.76% from the current price. The Meyka grade is C+ (59.35/100) and we list HOLD as the current suggestion. Traders focused on high-volume movers should verify prints, prefer limit orders, and size positions for fast reversals. Forecasts are model-based projections and not guarantees. Use strict risk controls before trading KETA.CN on the CNQ in CAD.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.